sec filing
AC
NASDAQ · ACON
Aclarion, Inc.
Healthcare · Medical - Healthcare Information Services
$2.64
Up+$0.09 (+3.53%)
Updated Sep 18, 2026, 2:16 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.59M
- P/E ratio
- -0.22
- Dividend yield
- 0.00%
- 52-week range
- $1.95 – $12.03
- Volume
- 35K
- Avg. volume
- 889.41K
Price performance
ACON price history
1M range · 20 trading sessions · Daily adjusted prices
ACON closed at $2.64 after 20 trading sessions, down 1.86% for the selected period.
- Last close
- $2.64
- Period change
- -1.86%
- Period low
- $2.29
- Period high
- $2.71
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $2.52 | $2.64 | $2.4101 | $2.64 | 35K |
| Sep 16, 2026 | $2.60 | $2.62 | $2.51 | $2.55 | 23.12K |
| Sep 15, 2026 | $2.54 | $2.62 | $2.5235 | $2.62 | 9.55K |
| Sep 14, 2026 | $2.63 | $2.63 | $2.5106 | $2.58 | 13.6K |
| Sep 11, 2026 | $2.5699 | $2.64 | $2.55 | $2.60 | 17.85K |
| Sep 10, 2026 | $2.465 | $2.60 | $2.4001 | $2.54 | 85.21K |
| Sep 9, 2026 | $2.40 | $2.45 | $2.3158 | $2.4201 | 13.08K |
| Sep 8, 2026 | $2.34 | $2.53 | $2.34 | $2.44 | 61.15K |
| Sep 4, 2026 | $2.261 | $2.41 | $2.26 | $2.35 | 44.1K |
| Sep 3, 2026 | $2.27 | $2.32 | $2.251 | $2.29 | 46.49K |
| Sep 2, 2026 | $2.325 | $2.42 | $2.25 | $2.31 | 63.71K |
| Sep 1, 2026 | $2.38 | $2.38 | $2.26 | $2.33 | 40.49K |
| Aug 31, 2026 | $2.40 | $2.40 | $2.31 | $2.35 | 37.13K |
| Aug 28, 2026 | $2.52 | $2.52 | $2.35 | $2.40 | 35.25K |
| Aug 27, 2026 | $2.37 | $2.52 | $2.31 | $2.52 | 54.08K |
| Aug 26, 2026 | $2.46 | $2.46 | $2.32 | $2.39 | 103.62K |
| Aug 25, 2026 | $2.65 | $2.65 | $2.43 | $2.49 | 175.09K |
| Aug 24, 2026 | $2.73 | $2.73 | $2.61 | $2.66 | 49.05K |
| Aug 21, 2026 | $2.75 | $2.83 | $2.58 | $2.71 | 44.41K |
| Aug 20, 2026 | $2.76 | $2.76 | $2.64 | $2.69 | 45.72K |
Latest ACON news
The latest Smart Investors Daily articles mentioning ACON.
Stock researchResearch & News · Analysis
Loading stock research…

